Research programme: biosimilars - American Biosources
Latest Information Update: 28 Jun 2019
At a glance
- Originator American Biosources
- Class Blood coagulation factors; Blood proteins; Colony-stimulating factors; Hormones; Interferons; Interleukins; Monoclonal antibodies; Vaccines
- Mechanism of Action Antibody-dependent cell cytotoxicity; Colony stimulating factor stimulants; Factor IX stimulants; Factor VIII stimulants; Glucosylceramidase stimulants; Haematopoietic cell growth factor stimulants; Hormone stimulants; Immunostimulants; Immunosuppressants; Interferon alpha stimulants; Interferon beta stimulants; Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anaemia; Endocrine disorders; Gaucher's disease; Haematological disorders; Hepatitis B; Leukaemia; Multiple sclerosis; Neutropenia; Rheumatoid arthritis
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for research development in Anaemia in USA
- 28 Jun 2019 No recent reports of development identified for research development in Endocrine-disorders in USA
- 28 Jun 2019 No recent reports of development identified for research development in Gaucher's-disease in USA